Drug	Gene	Type	Source
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	AR	Text_Mining(decreases(activity))	CTD
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	AR	Potency-Replicate_1=9.4392(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	AR	Ratio Potency (uM)=12.9418(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	AR	Potency-Replicate_1=13.4481(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	ESR1	Potency-Replicate_1=0.3758(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	ESR1	Potency-Replicate_1=0.9521(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	ESR1	Ratio Potency (uM)=1.89773(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	GMNN	Potency=18.8375(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	NR3C1	Potency-Replicate_1=7.5624(uM)	D4 PubChem
13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol	NR3C1	None=None(uM)	D4 PubChem